Gynecologic Oncology (2019 IF: 4.623), an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest, are published.
Gynecologic Oncology: current issue
- Sentinel lymph node biopsy at the time of hysterectomy for early-stage cervical cancer: A cost-effectiveness analysis
- Physical activity and lower extremity lymphedema among endometrial cancer survivors: A population-based cross-sectional study
- Rechallenge with platinum-based chemotherapy in patients with platinum-resistant ovarian carcinoma: A cohort study
- Prognostic value of assessing ctDNA in patients with endometrial carcinoma – an international multicenter study
- The genomic landscape of distant metastatic endometrial cancer
- Predicting lymph node metastases in three different vulvar squamous cell carcinoma subgroups
- Real-world efficacy and toxicity of olaparib maintenance therapy in Korean ovarian cancer patients with an exploratory analysis of BRCA mutations
- Efficacy of induction chemotherapy during the COVID-19 pandemic for treatment of locally advanced cervical cancer in Botswana
- Metformin for patients with advanced stage ovarian cancer: A randomized phase II placebo-controlled trial
- Role of adjuvant radiotherapy modality on clinical outcomes for early-stage uterine carcinosarcoma
- Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278)
- A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study
- Ultrasound-based versus immediate biopsy-based management of postmenopausal bleeding in non-Hispanic Black and non-Hispanic White individuals
- Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278)
- Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study
- Exosome transmit the ability of migration and invasion in heterogeneous ovarian cancer cells by regulating autophagy via targeting hsa-miR-328
- Chemotherapy Response Score (CRS): A comprehensive review of its prognostic and predictive value in High-Grade Serous Carcinoma (HGSC)
- Exploring the differences between BRCA mutated and HRwild-type high grade serous ovarian cancer: A multiomic analysis
- Bevacizumab beyond progression: Impact of subsequent bevacizumab re-treatment in patients with ovarian, fallopian tube, and peritoneal cancer after progression
- Research advances CRISPR gene editing technology generated models in the study of epithelial ovarian carcinoma
- Adenomyosis associated with endometrial cancer: Possible correlation with pathological, immunohistochemical and molecular characteristics
- Defining “enlarged” sentinel lymph nodes in the setting of endometrial cancer: What is the size cut-off?
- Histology-specific prognostic significance of isolated tumor cells, micrometastases, and macrometastases in endometrial cancer
- Impact of telehealth legislation on gynecologic oncology services: Policy updates
- HER2 expression in a molecularly defined cohort of endometrial cancer patients: The SPECTRUM study
- A clinical study of tremelimumab, alone or in combination with olaparib, for recurrent epithelial ovarian cancer
- Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery
- All-cause mortality and neighborhood social vulnerability among women with ovarian cancer
- WRN dependency in dMMR/MSI-H endometrial cancer: Clinical perspectives of a novel synthetic lethality strategy
- Signal transduction pathway activity in adult-type granulosa cell tumor samples